What is MedPharmics?
MedPharmics is a physician-owned clinical research organization based in the Greater New Orleans Metro Area. Operating as a consortium of physicians across multiple specialties, the company is committed to advancing medical science through rigorous clinical trials. MedPharmics leverages the extensive experience of its carefully selected staff, led by Medical Director Dr. Robert Jeanfreau, a Certified Principal Investigator. The organization's sub-investigators are board-certified specialists who enhance patient enrollment and provide deep clinical expertise. Patient recruitment is facilitated through the company's physician databases, ensuring access to individuals with known medical histories. MedPharmics actively engages in both inpatient and outpatient studies, developing tailored strategies to meet protocol objectives and client goals.
How much funding has MedPharmics raised?
MedPharmics has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for MedPharmics?
The substantial capital infusion, particularly the recent strategic investment, positions MedPharmics for accelerated growth and enhanced research capabilities. As a late-stage company, this financing is likely to fuel expansion into new therapeutic areas, bolster its research infrastructure, and potentially broaden its geographic reach. MedPharmics' focus on physician ownership and a strong, experienced research team provides a solid foundation for attracting further investment and forging new partnerships within the pharmaceutical and biotechnology industries. The company's ability to attract significant capital suggests strong confidence from investors in its business model and its contribution to clinical research.
See full MedPharmics company page
